These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10830255)
1. A risk-benefit assessment of drugs used for neonatal chronic lung disease. Sweet DG; Halliday HL Drug Saf; 2000 May; 22(5):389-404. PubMed ID: 10830255 [TBL] [Abstract][Full Text] [Related]
2. Current perspectives on the drug treatment of neonatal respiratory distress syndrome. Sweet DG; Halliday HL Paediatr Drugs; 1999; 1(1):19-30. PubMed ID: 10937476 [TBL] [Abstract][Full Text] [Related]
3. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
4. Modeling and remodeling of the lung in neonatal chronic lung disease: implications for therapy. Sweet DG; Halliday HL Treat Respir Med; 2005; 4(5):347-59. PubMed ID: 16137192 [TBL] [Abstract][Full Text] [Related]
5. Evolution of respiratory mechanics in preterm babies after surfactant administration in the neonatal period. Parmigiani S; Panza C; Bevilacqua G Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():65-73. PubMed ID: 10021719 [TBL] [Abstract][Full Text] [Related]
7. A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome. Walti H; Monset-Couchard M Drug Saf; 1998 May; 18(5):321-37. PubMed ID: 9589844 [TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. Schreiber MD; Gin-Mestan K; Marks JD; Huo D; Lee G; Srisuparp P N Engl J Med; 2003 Nov; 349(22):2099-107. PubMed ID: 14645637 [TBL] [Abstract][Full Text] [Related]
14. Airway remodelling in chronic lung disease of prematurity. Sweet DG; Halliday HL; Warner JA Paediatr Respir Rev; 2002 Jun; 3(2):140-6. PubMed ID: 12297062 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic strategies in acute respiratory distress syndrome. Leeman M; Vincent JL Curr Opin Anaesthesiol; 1998 Apr; 11(2):123-8. PubMed ID: 17013208 [TBL] [Abstract][Full Text] [Related]
16. Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease. Sucre J; Haist L; Bolton CE; Hilgendorff A Front Med (Lausanne); 2021; 8():665152. PubMed ID: 34136503 [TBL] [Abstract][Full Text] [Related]
17. Oxidative injury of the pulmonary circulation in the perinatal period: Short- and long-term consequences for the human cardiopulmonary system. de Wijs-Meijler DP; Duncker DJ; Tibboel D; Schermuly RT; Weissmann N; Merkus D; Reiss IKM Pulm Circ; 2017 Mar; 7(1):55-66. PubMed ID: 28680565 [TBL] [Abstract][Full Text] [Related]
19. Future developments in the pharmacotherapy of lung disease. Van der Kuy A Pharm Weekbl Sci; 1992 Aug; 14(4A):221-3. PubMed ID: 1437503 [TBL] [Abstract][Full Text] [Related]
20. Who Is at Risk? The Role of Airway Imaging in Chronic Lung Disease Risk Assessment. Kirby M; Coxson HO Ann Am Thorac Soc; 2018 Jun; 15(6):669-670. PubMed ID: 29856248 [No Abstract] [Full Text] [Related] [Next] [New Search]